Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Demetriou, CA

Christopher G. Demetriou, Redwood City, CA US

Patent application numberDescriptionPublished
20110010715Multi-Thread Runtime System - A runtime system implemented in accordance with the present invention provides an application platform for parallel-processing computer systems. Such a runtime system enables users to leverage the computational power of parallel-processing computer systems to accelerate/optimize numeric and array-intensive computations in their application programs. This enables greatly increased performance of high-performance computing (HPC) applications.01-13-2011

Patent applications by Christopher G. Demetriou, Redwood City, CA US

Marios D. Demetriou, Los Angeles, CA US

Patent application numberDescriptionPublished
20090014096HIGH CORROSION RESISTANT Zr-Ti BASED METALLIC GLASSES - Bulk solidifying amorphous alloys (BMGs) having improved corrosion resistance properties; and more particularly a sub-set of Zr—Ti-based BMGs having improved corrosion resistance properties are provided. The BMG compositions are formed by carefully controlling the concentration of, or removing altogether, highly electronegative elements, such as Ni and Cu from Zr—Ti-based bulk solidifying amorphous alloys thereby producing BMG materials with corrosion resistance properties that far exceed those of current commercially available BMGs and most conventional alloys. The elimination of these electronegative materials also opens the possibility of new uses for BMGs, including in biological applications.01-15-2009
20090053476MULTILAYERED CELLULAR METALLIC GLASS STRUCTURES AND METHODS OF PREPARING THE SAME - Multi-layered cellular metallic glass structures and methods of preparing the same are provided. In one embodiment, the cellular metallic glass structure includes at least one patterned metallic glass sheet and at least one additional sheet. The at least one patterned metallic glass sheet may include multiple sheets connected together to form a group of sheets, and the structure may include a group of sheets sandwiched between two outer sheets. The patterned metallic glass sheets may be patterned by thermoplastically forming two- and/or three-dimensional patterns in the metallic glass sheets. The metallic glass cellular structures are useful in a wide variety of applications, including but not limited to blast protection applications, energy absorption applications, structural support applications, biomedical implant applications, heat exchanger applications, thermal management applications, electrical shielding applications, magnetic shielding applications, and debris and radiation shielding for aerospace and outer space applications.02-26-2009
20090162629NI AND CU FREE PD-BASED METALLIC GLASSES - The invention is directed to Pd-based metallic glass alloys useful in biomedical applications having no Ni or Cu. Exemplary metallic glass alloys are represented by A06-25-2009
20090236017FORMING OF METALLIC GLASS BY RAPID CAPACITOR DISCHARGE - An apparatus and method of uniformly heating, rheologically softening, and thermoplastically forming metallic glasses rapidly into a net shape using a rapid capacitor discharge forming (RCDF) tool are provided. The RCDF method utilizes the discharge of electrical energy stored in a capacitor to uniformly and rapidly heat a sample or charge of metallic glass alloy to a predetermined “process temperature” between the glass transition temperature of the amorphous material and the equilibrium melting point of the alloy in a time scale of several milliseconds or less. Once the sample is uniformly heated such that the entire sample block has a sufficiently low process viscosity it may be shaped into high quality amorphous bulk articles via any number of techniques including, for example, injection molding, dynamic forging, stamp forging, and blow molding in a time frame of less than 1 second.09-24-2009
20100230012AMORPHOUS PLATINUM-RICH ALLOYS - According to embodiments of the present invention, an amorphous alloy includes at least Pt, P, Si and B as alloying elements, and has a Pt weight fraction of about 0.925 or greater. In some embodiments, the Pt weight fraction is about 0.950 or greater.09-16-2010
20100300148TOUGH IRON-BASED BULK METALLIC GLASS ALLOYS - A family of iron-based, phosphor-containing bulk metallic glasses having excellent processibility and toughness, methods for forming such alloys, and processes for manufacturing articles therefrom are provided. The inventive iron-based alloy is based on the observation that by very tightly controlling the composition of the metalloid moiety of the Fe-based, P-containing bulk metallic glass alloys it is possible to obtain highly processable alloys with surprisingly low shear modulus and high toughness.12-02-2010

Patent applications by Marios D. Demetriou, Los Angeles, CA US

Michael Demetriou, Irvine, CA US

Patent application numberDescriptionPublished
20080227750COMPOSITIONS AND METHODS FOR REGULATING RECEPTOR CLUSTERING - The invention relates to isolated complexes comprising one or more galectin associated with a Mgat5 modified glycan or polylactosamine modified glycan, and isolated lectin-Mgt5 modified glycan lattice comprising an array of mulitvalent interactions among lectins, Mgat5 modified glycans, polylactosamine modified glycans, and/or glycoproteins. Methods for evaluating a test compound for its ability to regulate receptor clustering through glycans on cell surfaces; and methods for regulating receptor clustering on cell surfaces comprising altering glycans on the cell surface associated with receptor clustering are also disclosed.09-18-2008
20090099130Methods and compositions for preventing and treating a disease related to glycan dysregulation - Contemplated compositions and methods are directed to prevent and/or treat various autoimmune diseases that are typically associated with glycan dysregulation, and especially autoimmune demyelinating diseases. Further especially contemplated aspects include animal models and systems for screening compounds to treat and/or prevent such diseases.04-16-2009